Breast tumors are very heterogeneous and can be classified in three main groups based on their molecular profile: luminal cancers that express both estrogen and progesterone receptors; HER2-positive cancers that express the tyrosine kinase receptor ERBB2; and triple negative (TN) cancers in which none of these receptors is detected. Here, NTRK1 is linked to cancer.